Category now obsolete? EMEA on non-parametrics [Nonparametrics]

posted by ElMaestro  – Denmark, 2008-08-22 15:23 (6503 d 11:32 ago) – Posting: # 2229
Views: 10,891

Good point, DLabes.
First: "In studies to determine bioequivalence after a single dose, AUCt, AUCoo, Cmax and tmax should be determined."
And then later:
"The assessment of bioequivalence is based upon 90% confidence intervals for the ratio of the population geometric means (test/reference) for the parameters under consideration."
One could get the impression that the pharmacokinetolophystic subgroup is requesting a parametric analysis of tmax including 90% CI's and the works, had it not been for the final punch:
"In studies to determine bioequivalence after a single dose, the parameters to be analysed are AUCt and Cmax."
...so why do they want tmax at all?

EM.

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
141 visitors (0 registered, 141 guests [including 42 identified bots]).
Forum time: 02:56 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5